(-0.58%) 5 022.21 points
(-0.12%) 37 753 points
(-1.15%) 15 683 points
(-0.11%) $82.60
(0.64%) $1.723
(-0.14%) $2 385.10
(-0.05%) $28.39
(-0.21%) $952.20
(0.01%) $0.937
(0.04%) $11.00
(-0.01%) $0.803
(0.00%) $94.06
Live Chart Being Loaded With Signals
Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies...
Stats | |
---|---|
Today's Volume | 33 300.00 |
Average Volume | 55 349.00 |
Market Cap | 38.94B |
EPS | ¥0 ( 2024-04-12 ) |
Next earnings date | ( ¥0 ) 2024-07-12 |
Last Dividend | ¥30.00 ( 2023-05-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 11.98 |
ATR14 | ¥4.42 (0.18%) |
Volume Correlation
Daito Pharmaceutical Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Daito Pharmaceutical Correlation - Currency/Commodity
Daito Pharmaceutical Financials
Annual | 2022 |
Revenue: | ¥45.10B |
Gross Profit: | ¥10.33B (22.91 %) |
EPS: | ¥227.64 |
Q2 | 2023 |
Revenue: | ¥11.93B |
Gross Profit: | ¥2.72B (22.75 %) |
EPS: | ¥54.99 |
Q1 | 2023 |
Revenue: | ¥12.18B |
Gross Profit: | ¥2.48B (20.32 %) |
EPS: | ¥43.22 |
Q4 | 2022 |
Revenue: | ¥10.53B |
Gross Profit: | ¥2.37B (22.50 %) |
EPS: | ¥59.48 |
Financial Reports:
No articles found.
Daito Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥30.00 (N/A) |
¥0 (N/A) |
¥30.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥4.55 | 2010-05-27 |
Last Dividend | ¥30.00 | 2023-05-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 24 | -- |
Total Paid Out | ¥396.45 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.59 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.75 | |
Div. Directional Score | 7.83 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8524.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7856.T | Ex Dividend Knight | 2023-10-30 | Semi-Annually | 0 | 0.00% | |
6999.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6351.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
5208.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
4312.T | Ex Dividend Junior | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
3482.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
2695.T | Ex Dividend Junior | 2023-10-30 | Annually | 0 | 0.00% | |
9064.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8150.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0739 | 1.500 | 8.52 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0452 | 1.200 | 8.49 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0668 | 1.500 | -0.369 | -0.554 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.73 | 0.800 | 1.334 | 1.068 | [1 - 3] |
quickRatioTTM | 1.071 | 0.800 | 8.41 | 6.73 | [0.8 - 2.5] |
cashRatioTTM | 0.279 | 1.500 | 9.56 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.105 | -1.500 | 8.26 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 333.57 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 467.87 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 467.87 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.151 | -1.500 | 9.39 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.220 | 1.000 | 9.66 | 9.66 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.102 | 1.000 | 9.96 | 9.96 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.942 | 1.000 | 5.88 | 5.88 | [0.2 - 2] |
assetTurnoverTTM | 0.611 | 0.800 | 9.26 | 7.41 | [0.5 - 2] |
Total Score | 11.91 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 11.03 | 1.000 | 8.99 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0668 | 2.50 | -0.237 | -0.554 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 467.87 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.42 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 467.87 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.435 | 1.500 | -6.23 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.161 | 1.000 | 8.47 | 0 | [0.1 - 0.5] |
Total Score | 3.75 |
Daito Pharmaceutical
Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators